Earth Science Tech Inc. (ETST) Signals Strong Confidence with Aggressive Q1 Share Buybacks

• Aggressive repurchase of its own stock by Earth Science Tech, a growing holding company focused on various aspects of the healthcare industry,  reflects management’s growing internal confidence in the company’s future trajectory.
• Over 3 million shares of common stock have been repurchased in current fiscal quarter, a significant acceleration in buybacks.
• Reduction in share dilution can consolidate existing equity and potentially boost earnings per share (“EPS”).

Earth Science Tech (OTC: ETST) is capturing the attention of the micro-cap market following a significant acceleration of its share repurchase program. Recent market data indicates that the company is aggressively buying back its own stock, a strategic corporate move that typically signals strong internal confidence in a company’s financial health, cash flow, and future trajectory.

According to current disclosures, Earth Science Tech has been highly active in its buyback program during its current fiscal first quarter of 2027. Over the course of this recent quarter, the company has successfully repurchased a total of 3,150,392 shares of its common stock.

What makes this figure particularly notable is the sheer velocity of the repurchases compared to historical data. To put this recent quarter into perspective, the 3.15 million shares bought back in just the first three months of Fiscal Q1 2027 represent over 83% of the total volume of shares the company purchased over the entire 12-month period of the preceding fiscal year ending 2026.

From a third-party analytical standpoint, when a company buys back more than four-fifths of its previous year’s total in a single quarter, it sends a distinct and bullish message to the market. Share repurchases of this magnitude generally highlight two key factors for investors:

• Reduction of Outstanding Shares: By repurchasing over 3.15 million shares, ETST decreases the total number of outstanding shares in the open market, which can consolidate existing equity and potentially boost earnings per share (“EPS”).
• Management Conviction: Accelerating a buyback program at this pace usually indicates that management and the board of directors believe the stock is currently undervalued by the market, and that investing capital directly back into the company yields a strong return on investment.

Earth Science Tech’s willingness to deploy capital into its own stock at such an accelerated rate is an indicator that current and prospective investors should watch closely. As ETST moves further into fiscal 2027, the market will be eager to see if this aggressive pace of share accumulation continues.

Data regarding Earth Science Tech, Inc.’s (ETST) outstanding shares, security details, and recent buyback activities can be verified directly via OTC Markets.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN